| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.18B | -24.4% |
| Cost of Revenue | $833.3M | -17.9% |
| Gross Profit | $350.1M | -36.4% |
| R&D Expense | $166.5M | +3.2% |
| SG&A Expense | $118.1M | +19.1% |
| Operating Income | -$240.4M | — |
| Pre-tax Income | -$261.7M | -1025.2% |
| Income Tax | $24.6M | +1268.7% |
| Net Income | -$286.3M | -1042.1% |
| EPS (Basic) | -$10.52 | -1056.4% |
| EPS (Diluted) | -$10.52 | -1074.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $117.9M | -41.5% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $66.0M | -58.9% |
| Inventory | $285.3M | -14.4% |
| Current Assets | $528.3M | -33.1% |
| Total Assets | $835.4M | -29.5% |
| Current Liabilities | $296.2M | -25.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$90.0M | -181.6% |
| Capital Expenditures | $12.3M | -58.8% |
| Investing Cash Flow | $2.2M | +104.7% |
| Financing Cash Flow | $2.9M | +102.0% |
| Free Cash Flow | -$102.3M | -65.3% |
| Total Liabilities |
| $359.7M |
| -23.1% |
| Stockholders' Equity | $475.7M | -33.6% |